STUDY QUESTION: Does ICSI improve reproductive outcomes compared with conventional IVF when used for non-male factor infertility in women aged 40 years and over?
MAIN RESULTS AND THE ROLE OF CHANCE: Baseline characteristics were similar between the two groups, except for the number of previous IVF cycles, which was higher in the ICSI group (1.0 vs. 0.6, P = 0.0001). Despite similar numbers of oocytes retrieved (7.2 vs. 6.5), when examining oocytes maturity (performed 2 h after oocyte retrieval in the ICSI group and after 18 h in the conventional IVF group), the conventional IVF group had a higher number of Metaphase II (MII) oocytes (6.1 vs. 4.7, P < 0.0001). The conventional IVF group also had higher numbers of zygotes formed (4.48 vs. 3.66, P = 0.001), more cycles with embryos transferred at the blastocyst stage (36 vs. 26%, P = 0.005) and more cycles where embryos were available for cryopreservation (26.4 vs. 19 .7%, P = 0.048), compared with the ICSI group. The fertilization rates (64 vs. 67%) and fertilization failure (9.0 vs. 9.7%) were similar. After logistic regression analysis controlling for confounders, the live birth rates were similar between the groups (11.9 vs. 9.6%). Subgroup analyses of women undergoing their first IVF cycle and women with ≤3 oocytes retrieved did not show an advantage of ICSI over conventional IVF.
LIMITATIONS, REASONS FOR CAUTION:
The retrospective nature of this study was a major limitation. The ICSI group had a higher number of previous IVF cycles, which could mean that ICSI was performed in poorer prognosis patients. Moreover, although this study is one of the largest studies to examine the question of whether ICSI is of value for older women with non-male factor infertility, based on a post hoc power analysis, it was still underpowered to detect differences in live birth rates, which can limit the conclusions of the study. Prospective studies are needed to confirm our findings.
Introduction
ICSI was introduced in 1992 and has developed as a method to treat couples with severe male factor infertility (Palermo et al., 1992) . However, in the last two decades, the use of ICSI has increased substantially, even among patients without male factor infertility. In the USA, the use of ICSI in IVF cycles has increased from 34% in 1996 to 76% in 2012 (Boulet et al., 2015) . The greatest increase was documented in cycles without male factor infertility, where ICSI use went from 15 to 67% during this same time period (Boulet et al., 2015) . In a recent report from the international committee for monitoring assisted reproductive technologies, it was shown that ICSI was used in 65% of IVF cycles in Europe (Dyer et al., 2016) . This report also highlighted that in some parts of the world, ICSI is performed in 100% of IVF cycles. Despite its increase use, there is no clear evidence that ICSI leads to improved reproductive outcomes. However, the scarcity of randomized trials makes it difficult to draw clear conclusions on the benefits of ICSI in non-male factor infertility (van Rumste et al., 2003) .
In a randomized controlled trial that included 415 couples with nonmale factor infertility, conventional IVF was associated with better fertilization rates and implantation rates, but with comparable live birth rates when compared with ICSI (Bhattacharya et al., 2001) . ICSI has been suggested as a treatment for couples with unexplained infertility (Check et al., 2011) or low oocyte yield (Luna et al., 2011) or for routine use to decrease the incidence of fertilization failure (Fishel et al., 2000) . However, the results of these studies have not shown any advantage of ICSI. The practice committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology concluded, in 2012, that there is insufficient evidence to support the routine use of ICSI in the absence of male factor infertility. Moreover, the lack of controlled trials and sufficient data regarding specific diagnoses, such as advanced maternal age, was highlighted (ASRM, 2012).
Women of advanced age undergoing infertility treatments are one of the least studied groups. The proportion of women seeking pregnancy after the age of 35 is on the rise, and many of these women will require IVF due to age-related infertility (Mills et al., 2011) . Oocytes retrieved from older women are often of lower quality compared with those from younger women (Korkmaz et al., 2015) . This quality issue is hypothesized to result in decreased fertilization with conventional IVF. Therefore, for many clinicians, ICSI is the preferred method of fertilization in this population. Nevertheless, clinical evidence is lacking to support this practice. The purpose of this study is to compare ICSI and conventional IVF in women aged 40 years or older with non-male factor infertility according to World Health Organisation (WHO) fifth edition semen analysis values (Cooper et al., 2010) . To our knowledge, no study has yet assessed the benefit of ICSI in this group of patients.
Materials and Methods

Patient population and inclusion criteria
A retrospective cohort study was conducted at a University Reproductive Center. All fresh IVF cycles performed in women aged 40 years or older from January 2012 to June 2015 were reviewed for possible inclusion. According to the clinic guidelines, women can be treated with autologous oocytes up to the age of 43. In order to be included in the study, the sperm analysis had meet the criteria of the WHO fifth edition sperm parameter values: total sperm count of at least 39 million, concentration ≥15 × 10 6 /ml, total motility ≥40%, progressive motility ≥32%, strict morphology ≥4% normal forms. Exclusion criteria included: more than three previous IVF cycles (including both failed cycles and cycles that ended in live births); previous IVF cycles with fertilization failure or low fertilization rates (<50%); the use of donor or frozen oocytes; PGD cycles; cycles with frozen sperm samples; minimal ovarian stimulation cycles and cycles with split insemination (IVF/ICSI) of sibling oocytes.
The primary outcome was live birth rate. The first IVF cycle performed during the study time period was included.
Stimulation protocol and embryology procedures
Ovarian stimulation was performed using mixed FSH/LH under pituitary suppression. One of three ovarian stimulation protocols was used: a microdose flare protocol, a fixed antagonist protocol or a mid-luteal long agonist protocol. Final oocyte maturation was induced with hCG when at least two follicles were >17 mm in diameter.
The decision regarding the insemination method was made by the treating physician. The fertility unit includes several clinicians that manage patients independently. With the lack of clinical guidelines regarding the preferred insemination method in this age group, it is the physician's decision of which insemination method to choose. This scenario reflects the practice dilemma care providers face. The fact that patients are older and have decreased fertility potential can explain the inclination toward performing ICSI to 'ensure' maximal fertilization. For ICSI cycles, cumulus stripping was performed 2 h after oocyte retrieval to examine oocyte maturation. Metaphase II (MII) oocytes were inseminated by ICSI using the partner's spermatozoa. ICSI was performed at least 1 h after removing the cumulus cells. Oocytes that did not complete maturation were discarded. Fertilization was assessed 16-18 h after insemination for the appearance of two distinct pro-nuclei and two polar bodies. In conventional IVF, oocyte-cumulus complexes were inseminated with 100 000/ml motile spermatozoa per insemination dish, containing 3-5 oocytes. The maturity status of the oocytes was not examined until after 16-18 h, at which time all of the inseminated oocytes were stripped from the cumulus cells to check for fertilization and the maturity status of the non fertilized oocytes (MII, MI or Germinal vesicle) was recorded.
The zygotes were cultured in cleavage medium (COOK Medical, Sydney, Australia). Embryonic development was assessed on Day 2 and on Day 3 after insemination. If there were at least three good quality embryos on Day 3, then culture was extended to the blastocyst stage in blastocyst medium (COOK Medical) and transfer occurred on Day 5. When there were only one to three good quality cleavage stage embryos, embryo transfer was performed on Day 2 or 3. According to provincial guidelines, up to two embryos can be transferred in this age group, with the preference being to transfer a single embryo at the blastocyst stage. Supernumerary good quality embryos were cryopreserved at the blastocyst stage.
Embryo quality
Cleavage embryos were defined as a good quality (Grade 1 or 2) if they had four cells on Day 2 and/or 7 or 8 cells on Day 3, contained <20% fragmentation, and exhibited no apparent morphological abnormalities. Poor quality embryos included fair quality (Grade 3) embryos, which had only two cells on Day 2, three to five cells on Day 3 and/or 20-50% fragmentation, and Grade 4 embryos with <3 cells by Day 3 and >50% fragmentation. On Day 5, embryos were scored for blastocyst formation. Blastocysts were graded according to the size of the blastocyst, the assessment of the inner cell mass (ICM) and trophectoderm development [≥3BB] (Gardner et al., 2004) . Good quality embryos (Grade 1 or 2) were defined as those where at least [3] the blastocele completely fills the embryo, [B] the ICM is loosely grouped with several cells and [B] the trophectoderm has a few cells forming a loose epithelium. Lower than 3BB quality embryos on Day 5 were defined as poor quality embryos (Grade 3 or 4). The clinic policy is to avoid transferring Grade 4 embryos, except in cases where only these embryos are available.
Outcomes measures
Pregnancy was defined as positive βhCG blood test 11-14 days after embryo transfer. Clinical pregnancy was defined as gestational sac seen on vaginal ultrasound scan by 6 weeks gestation. Live birth was defined as delivery of a live fetus at gestational age of ≥24 weeks.
Statistical analysis
Continuous data were confirmed for normal distribution using the Kolmogorov-Smirnov test. All were normally distributed. Baseline data were compared using non-paired t-test or chi-square tests. Outcomes were compared with logistic regression analysis, controlling for confounding effects that included the number of previous IVF cycles, number of MII oocytes, number of embryos transferred and embryo stage. We also controlled for maternal and paternal age due to its potential clinical significance although these were similar between the groups. Data are presented as percentages or mean ± standard deviation. Two-sided P-values of ≤ 0.05 were accepted as statistically significant. SPSS version 22 (IBM SPSS, USA) was used for data analyses.
Results
During the study period, 745 patients met the inclusion criteria. Of these, 490 patients underwent ICSI and 255 patients underwent conventional IVF. Baseline characteristics are presented in Table I . All baseline characteristics were similar between the IVF and ICSI groups except for the mean number of previous IVF cycles. This result was higher in the ICSI group (1 vs. 0.6, P = 0.0001)
The number of the current IVF cycle treatment and the infertility diagnosis are shown in Table II . More than 70% of patients in each group were undergoing their first or second IVF cycle. The infertility diagnoses did not differ between the groups. The IVF treatment protocol, total gonadotropin dose used and the peak serum estradiol levels achieved were similar between the two groups. Results are presented as percentage or mean ± SD. PCOS, polycystic ovary syndrome; MDF, microdose flare protocol. a n (%).
When evaluating cycles outcomes (Table III) , despite a similar number of oocytes retrieved, there were more MII oocytes in the IVF than in the ICSI group, although oocyte maturity was assessed at different times in the two protocols. It was also noted that the fertilization rate per oocyte retrieved was higher in the IVF than in the ICSI group. The IVF group had more 2PN embryos formed and more cycles with embryos that were cultured to the blastocyst stage. Due to provincial policy related to blastocyst transfer, more cycles with a single embryo transfer were performed in the IVF group. There were no differences in embryos quality between the groups. The IVF group had more cycles with remaining embryos to freeze and a higher mean number of embryos frozen per cycle than the ICSI-treated subjects. After controlling for confounders, the clinical pregnancy rates and live birth rates did not differ between the groups.
The ICSI group had more previous IVF cycles, and so it can be argued that ICSI achieved similar live birth rates despite being used in poor prognosis patients. In order to target this potential bias, we performed two subgroups analysis that included 'good prognosis' women undergoing their first IVF cycle and poor prognosis women with low oocyte yield. The first analysis included women undergoing their first IVF cycle. The results are presented in Table IV . Similar to the entire group, the number of oocytes retrieved was similar in both groups, However, there were more MII oocytes, more 2PN embryos and more cycles with embryos cultured to the blastocyst stage among the IVF compared with the ICSI-treated women, but the pregnancy outcomes were similar between the groups. Although there is a trend toward lower live births in both groups compared with the whole group, it can reflect the more optimal stimulation that women had in their subsequent cycles compared with the first ovarian stimulation cycle.
The second analysis included poor prognosis women with ≤3 oocytes retrieved (Table V) . Importantly, fertilization failure and live birth rates were similar between the groups.
Discussion
The results of this study demonstrate that conventional IVF and ICSI achieved similar live birth rates in women of advanced maternal age when applied for non-male factor infertility. However, upon examining cycles characteristics, ICSI may have a detrimental effect on outcomes. Although similar numbers of oocytes were retrieved in both groups, the IVF group had a higher numbers of MII oocytes, higher fertilization rates per oocyte retrieved and higher numbers of zygotes formed. A potential explanation for this difference is that in ICSI treatment, oocytes are scrutinized for maturity upon insemination, and immature oocytes are discarded from the cohort, while in conventional IVF, the maturity of oocytes is not examined until 16-18 h after insemination and the cumulus-oocyte complex is maintained intact in culture allowing more oocytes to complete maturation and subsequently fertilize 13 (9.9%) 13 (9.2%) 0.14 a Baseline characteristics were similar between the groups b n (%). c P-value after logistic regression controlling for confounders. over time. A similar findings of higher numbers of mature oocytes available in conventional IVF compared with ICSI were reported in previous studies. In a randomized controlled trial that included 415 couples with non-male factor infertility and mean female age of 31 years, the IVF group had a higher number of inseminated oocytes and a higher fertilization rate per collected oocyte (58 vs. 47%, P < 0.0001), despite similar number of oocytes retrieved (11 oocytes in each group) (Bhattacharya et al., 2001) . In a retrospective study that compared conventional IVF versus ICSI in non-male factor infertility, the number of oocytes retrieved was similar (9.0 vs. 8.2); however, a higher number of oocytes were inseminated (9.0 vs. 7.4, P = 0.02) and more zygotes were formed in the IVF group (6.6 vs. 5.0, P = 0.006) (Kim et al., 2007) . Another possible explanation for the apparent advantage of conventional IVF regarding fertilization rates and zygote formation is oocyte degeneration resulting from mechanical damage during the ICSI procedure, which is reported to occur in 5-19% of injected oocytes (Ebner et al., 2001; Yavas et al., 2001; Rosen et al., 2006) . ICSI is an invasive technique that can damage the oocyte membrane and cytoplasm and requires experienced laboratory technicians. In a prospective trial of 305 ICSI cycles that included 2924 oocytes and evaluated certain variations of ICSI techniques on outcomes, the oocyte degeneration rate ranged from 5 to 11% and it differed between laboratory technicians performing it. Moreover, the volume of aspirated oocyte cytoplasm during the procedure affected the percentage of embryos reaching the blastocyst stage (Dumoulin et al., 2001) . In our study, data on oocyte degeneration were not collected; however, the higher number of zygotes available in the IVF group could be partially explained by oocyte degeneration in the ICSI group. The availability of a higher number of MII oocytes and zygotes resulted in more cycles with embryos cultured to the blastocyst stage. It also resulted in a higher number of cycles with embryo cryopreservation and higher mean number of embryos available for cryopreservation in the IVF group. Although these advantages did not result in a higher live birth rates in a fresh embryo transfer, it has the potential to result in improved cumulative live birth rates in the IVF group.
In the ICSI group, a higher mean number of embryos were transferred (1.57 vs. 1.48, P = 0.02). Although it was statistically significant, this difference is not likely clinically significant and it did not result in higher live birth rates. More importantly, the insemination method did not seem to affect embryo quality. Perhaps the most reliable studies to show that the insemination method has no effect on embryo quality are those that applied split insemination in sibling oocytes from the same cohort. These studies showed that there was no difference in embryo quality, regardless of the insemination method used (Staessen et al., 1999; Hershlag et al., 2002; Yoeli et al., 2008) .
Oocytes of older women are theorized to have structural defects that might reduce fertilization potential, potentially making ICSI the preferred insemination method to avoid fertilization failure. This occurs in 5-15% of IVF cycles in the general IVF population (Molloy et al., 1991; Roest et al., 1998) . However, there is no clinical data to support these assumptions. Check et al. (2012) examined oocytes fertilizations in 364 IVF cycles in women aged 45 year or older with nonmale factor infertility and found similar fertilization rates (51% vs 56%) and fertilization failure rates (27% vs 28%) for IVF and ICSI respectively and concluded that older women are not at increased risk of decreased fertilization with conventional IVF. In our study, fertilization failure occurred in 9% of cycles and it did not differ between the IVF and ICSI groups.
To the best of our knowledge, this study is the first to specifically compare conventional IVF and ICSI in women aged 40 years and over. It is the first to report data about fertilization rates, fertilization failure, cycle cancellation, embryo quality and pregnancy outcomes in this age group. A strength of the study is the large number of subjects included. However, the retrospective nature of the study could be a source of bias. As shown in patient characteristics, women in the ICSI group had a higher number of previous IVF cycles (1.0 vs. 0.6, P = 0.0001) which could be interpreted as the ICSI group including more 'complex' cases with poorer prognosis. In order to reduce bias, we did two subgroup analyses. The first was to analyze women undergoing their first IVF cycle, which comprised 41% of the total study population. Interestingly, the results were similar to the whole group with similar number of oocytes retrieved, but more MII oocytes, more zygote formation, more cycles with embryos cultured to the blastocyst stage and more cycles with a single embryo transfer in the IVF group. The second subgroup analysis included women with low oocyte yield (≤3 oocytes). Again no difference in outcomes was noted. It can be concluded that the choice of the insemination method should be based on sperm parameters only, including for older women with low oocyte yield, as the use of ICSI did not reduce the incidence of fertilization failure (26 vs. 23%, P = 0.4).
A post hoc power analysis was performed to determine how many subjects would have been required to find a difference between the outcomes in the ICSI and IVF groups. Live birth was selected as it is the most important clinical parameter. The live birth rates presented in Table III were used. This calculation showed that almost 6000 women should be included to show that live birth rates would have been lower with ICSI than with conventional IVF. This large number precludes clinical significance, despite the possibility of statistical significance, and therefore supports the conclusions of this study.
When counselling women regarding the insemination method, safety and the added cost of ICSI should be discussed. In a recent large population cohort study that included 308 974 births and 6163 births resulting from IVF, the rate of birth defects in IVF without ICSI was similar to that in the general population. However, the use of ICSI was associated with increased risk of birth defects (OR 1.57; 95% CI, 1.30-1.90) even after controlling for confounders (Davies et al., 2012 is required to define the risks of ICSI when used for indications other than male factor infertility. The added cost of ICSI should be discussed, particularly because it seems to offer no benefit when male factor is not present.
In conclusion, this study shows that the use of ICSI for the sole indication of advanced maternal age does not have additional benefits and it is associated with similar reproductive outcomes compared with conventional IVF.
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